Agenda/Scientific Program

View the Scientific Program

The Symposium brings together industry, regulatory, and academic professionals to enable the exchange of scientific ideas and dialogue that form the basis of evolving regulatory practices in the development of these diverse and innovative products. In 2024, regulatory participation included the European Medicines Agency (EMA), US Food and Drug Administration (FDA), Health Canada, and Pharmaceuticals and Medical Devices Agency (PMDA). Plenary and parallel tracks as well as roundtable discussions and NEW flash poster talks will offer additional content and opportunities to engage in meaningful discussions. We look forward to an informative Symposium and hope to see you there. Be ready to network, collaborate, and expand your knowledge. Session topics include:

  • Advancing Stem Cell Therapy Development: Overcoming Challenges and Expanding Horizons 
  • Characterization of Viral Vectors 
  • FDA START Program 
  • Investing in CGT 
  • Gene Editing 
  • Global Regulators
  • Non-Profit/Alliance 
  • Non-Viral Approaches for Ex-vivo and In-vivo Gene Therapies 
  • Optimizing the Analytical Testing
  • Platform Development 

Blue and orange graphic with professional headshot of male and text 'Cell and Gene Therapy Products Symposium Keynote Speaker Fyodor Urnov, University of California, Berkeley June 10-12, 2025 Rockville, MD'
Keynote Speaker Bio

Fyodor Urnov
Professor of Molecular Therapeutics 
University of California, Berkeley and Innovative Genomics Institute (IGI)

Fyodor Urnov is a Professor of Molecular Therapeutics at UC Berkeley and a Scientific Director at its Innovative Genomics Institute (IGI). He co-developed the toolbox of human genome and epigenome editing, co-named genome editing, and was on the team that advanced all of its first-in-human applications to the clinic. He also led the effort that identified the genome editing target for an approved medicine to treat sickle cell disease and beta-thalassemia. A major goal for the field of genome editing and a key focus of Fyodor's work is expanding access to CRISPR therapies for genetic disease. As part of that effort Fyodor directs the Danaher-IGI Beacon for CRISPR Cures - a first-in-class academia-industry partnership developing and advancing to the clinic scalable CRISPR-based approaches to treat diseases of the immune system.


Frequently Asked Questions

Call for Roundtable Volunteers

Engage directly with your peers by volunteering as a scribe or facilitator for roundtable discussions.

Blue and orange graphic with text 'Cell & Gene Therapy Products June 10-12, 2025 Rockville, MD'

Register Now

Save your spot for Cell & Gene Therapy Products on June 10-12, 2025 in Rockville, MD USA. Register for in-person attendance by May 27, 2025, or for virtual attendance by June 5, 2025.

Blue and orange graphic with text 'Cell & Gene Therapy Products June 10-12, 2025 Rockville, MD'

Promo

Come for the Summit, Stay for the Symposium!* Register for both at the same time and save 10% on registration fees! Use Promo Code CGTPSS25_10

*This promo is available for in-person registrations only. Promo code must be applied before checking out. Promo codes cannot be retroactively applied. In order to qualify for this promotion, you must register for both the Symposium and Summit in one transaction. You will not be eligible for the promotion if you register in separate transactions.

"These were very engaging discussions!!! Thank you CASSS CGTP organizers for the opportunity to bring us together around the table!"
—Basak Clements, CGTP 2024 Attendee
"Excellent talks and panel discussions!!! A great conference for Cell and Gene Therapy CMC folks"
Seshu Tyagarajan, CGTP 2024 Attendee